- Investing Ideas
- /
- U.S. Large Cap High Growth Potential
U.S. Large Cap High Growth Potential
Results
252
10 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
252 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ARES | US$175.52 | 5.0% | 60.7% | US$54.8b | US$174.38 | PE82x | E46.3% | 2.1% | Diversified Financials | ||
ALNY | US$244.89 | 4.0% | 50.3% | US$31.8b | US$301.21 | PS15.1x | E70.7% | n/a | Pharmaceuticals & Biotech | ||
ONON | US$58.13 | 12.0% | 104.1% | US$18.0b | US$58.64 | PE132.1x | E29.6% | n/a | Consumer Durables | ||
SRPT New | US$114.23 | 9.3% | 37.8% | US$10.6b | US$189.62 | PE89.5x | E42.6% | n/a | Pharmaceuticals & Biotech | ||
NVDA | US$141.95 | -0.02% | 197.1% | US$3.6t | US$170.44 | PE55.1x | E24.2% | 0.03% | Semiconductors | ||
NU | US$13.91 | -1.1% | 69.4% | US$64.4b | US$15.94 | PB8.7x | E29.0% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
BX | US$199.05 | 9.7% | 86.0% | US$237.0b | US$168.90 | PE68.7x | E27.9% | 1.7% | Diversified Financials | ||
KSPI | US$104.00 | -5.4% | 8.3% | US$19.7b | US$139.13 | PE10.1x | E23.7% | 6.6% | Diversified Financials | ||
SMCI | US$33.15 | 78.4% | 16.0% | US$17.4b | US$40.32 | PE16.1x | E24.3% | n/a | Tech | ||
DUOL | US$351.97 | 14.5% | 58.9% | US$15.0b | US$327.23 | PE178.4x | E41.6% | n/a | Consumer Services | ||
OWL | US$24.55 | 8.7% | 81.0% | US$36.3b | US$23.55 | PE130.5x | E59.2% | 2.9% | Diversified Financials | ||
RYAN | US$73.53 | 3.7% | 59.8% | US$18.8b | US$73.48 | PE90.5x | E44.5% | 0.6% | Insurance | ||
SN | US$98.34 | -2.5% | 105.8% | US$14.1b | US$121.69 | PE38.4x | E22.8% | 1.1% | Consumer Durables | ||
DASH | US$177.24 | 4.6% | 88.9% | US$71.9b | US$171.55 | PS7.3x | E56.0% | n/a | Consumer Services | ||
NTNX | US$73.18 | 5.2% | 77.1% | US$19.0b | US$75.53 | PS9.1x | E85.0% | n/a | Software | ||
EXE | US$99.43 | 4.7% | 21.0% | US$23.3b | US$102.65 | PE90.5x | E93.0% | 2.5% | Energy | ||
VRT | US$140.15 | 16.0% | 228.4% | US$53.1b | US$139.69 | PE90.5x | E31.2% | 0.07% | Capital Goods | ||
TER | US$108.21 | 5.5% | 17.0% | US$17.2b | US$134.62 | PE34.3x | E21.7% | 0.4% | Semiconductors | ||
CTRA | US$27.63 | 8.0% | 3.2% | US$20.2b | US$32.30 | PE16.5x | E29.8% | 3.0% | Energy | ||
CVNA | US$259.36 | 7.6% | 725.7% | US$52.5b | US$245.81 | PE1960.6x | E44.9% | n/a | Retail | ||
ZS | US$210.96 | 4.7% | 9.3% | US$31.6b | US$218.01 | PS14.8x | E39.3% | n/a | Software | ||
SPOT | US$475.04 | 3.6% | 161.4% | US$95.1b | US$472.16 | PE131.5x | E29.6% | n/a | Media | ||
XPEV | US$11.91 | -6.5% | -35.6% | US$11.7b | US$14.52 | PS2.2x | E64.4% | n/a | Automobiles |